Effects of acute nicotine on brain function in healthy smokers and non-smokers: Estimation of inter-individual response heterogeneity
Tài liệu tham khảo
Amiez, 2006, Local morphology predicts functional organization of the dorsal premotor region in the human brain, J. Neurosci., 26, 2724, 10.1523/JNEUROSCI.4739-05.2006
Berrettini, 2005, Pharmacotherapy and pharmacogenetics of nicotine dependence, Am. J. Psychiatry, 162, 1441, 10.1176/appi.ajp.162.8.1441
Borsook, 2008, A ‘BOLD’ experiment in defining the utility of fMRI in drug development, Neuroimage, 42, 461, 10.1016/j.neuroimage.2008.04.268
Brett, M., Anton, J.L., Valabregue, R., Poline, J.B., 2002a. Region of interest analysis using an SPM toolbox [abstract]. Presented at the 8th International Conference on Functional Mapping of the Human Brain, June 2–6, 2002, Sendai, Japan. Neuroimage 15.
Brett, 2002, The problem of functional localization in the human brain, Nat. Rev. Neurosci., 3, 243, 10.1038/nrn756
Calkins, 2003, Smooth pursuit and antisaccade performance evidence trait stability in schizophrenia patients and their relatives, Int. J. Psychophysiol., 49, 139, 10.1016/S0167-8760(03)00101-6
Callicott, 2003, Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down, Am. J Psychiatry, 160, 2209, 10.1176/appi.ajp.160.12.2209
de Jongh, 2008, Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories, Neurosci. Biobehav. Rev., 32, 760, 10.1016/j.neubiorev.2007.12.001
Dépatie, 2002, Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study, Neuropsychopharmacology, 27, 1056, 10.1016/S0893-133X(02)00372-X
Ettinger, 2003, Pharmacological studies of smooth pursuit and antisaccade eye movements in schizophrenia: current status and directions for future research, Curr. Neuropharmacology, 1, 285, 10.2174/1570159033477017
Ettinger, 2003, Reliability of smooth pursuit, fixation, and saccadic eye movements, Psychophysiology, 40, 620, 10.1111/1469-8986.00063
Ettinger, 2006, Antisaccade performance in monozygotic twins discordant for schizophrenia: the Maudsley twin study, Am. J. Psychiatry, 163, 543, 10.1176/appi.ajp.163.3.543
Feyerabend, 1990, A rapid gas–liquid chromatographic method for the determination of cotinine and nicotine in biological fluids, J. Pharm. Pharmacol., 42, 450, 10.1111/j.2042-7158.1990.tb06592.x
Friston, 1996, Detecting activations in PET and fMRI: levels of inference and power, Neuroimage, 4, 223, 10.1006/nimg.1996.0074
Garavan, 2000, Practice-related functional activation changes in a working memory task, Microsc. Res. Tech., 51, 54, 10.1002/1097-0029(20001001)51:1<54::AID-JEMT6>3.0.CO;2-J
Giessing, 2007, fMRI data predict individual differences of behavioral effects of nicotine: a partial least square analysis, J. Cogn. Neurosci., 19, 658, 10.1162/jocn.2007.19.4.658
Gilbert, 2007, Comment on “Wandering minds: the default network and stimulus-independent thought”, Science, 317, 43, 10.1126/science.1140801
Green, 2000, Antisaccade and smooth pursuit eye movements in healthy subjects receiving sertraline and lorazepam, J. Psychopharmacol., 14, 30, 10.1177/026988110001400103
Greenwood, 2007, Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia, Arch. Gen. Psychiatry, 64, 1242, 10.1001/archpsyc.64.11.1242
Grosbras, 2005, Cortical regions involved in eye movements, shifts of attention, and gaze perception, Hum. Brain Mapp., 25, 140, 10.1002/hbm.20145
Hahn, 2007, Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network, J. Neurosci., 27, 3477, 10.1523/JNEUROSCI.5129-06.2007
Hallett, 1978, Primary and secondary saccades to goals defined by instructions, Vision Res., 18, 1279, 10.1016/0042-6989(78)90218-3
Hanna, 2006, Nicotine effect on cardiovascular system and ion channels, J. Cardiovasc. Pharmacol., 47, 348, 10.1097/01.fjc.0000205984.13395.9e
Heatherton, 1991, The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire, Br. J. Addict., 86, 1119, 10.1111/j.1360-0443.1991.tb01879.x
Heishman, 1998, What aspects of human performance are truly enhanced by nicotine?, Addiction, 93, 317, 10.1080/09652149835864
Hutton, 2006, The antisaccade task as a research tool in psychopathology: a critical review, Psychophysiology, 43, 302, 10.1111/j.1469-8986.2006.00403.x
Jacobsen, 2002, Impact of intravenous nicotine on BOLD signal response to photic stimulation, Magn. Reson. Imaging, 20, 141, 10.1016/S0730-725X(02)00494-0
Jacobsen, 2004, Nicotine effects on brain function and functional connectivity in schizophrenia, Biol. Psychiatry, 55, 850, 10.1016/j.biopsych.2003.12.023
Kumari, 2005, Nicotine use in schizophrenia: the self medication hypotheses, Neurosci. Biobehav. Rev., 29, 1021, 10.1016/j.neubiorev.2005.02.006
Kumari, 2003, Cognitive effects of nicotine in humans: an fMRI study, Neuroimage, 19, 1002, 10.1016/S1053-8119(03)00110-1
Lakier, 1992, Smoking and cardiovascular disease, Am. J. Med., 93, 8S, 10.1016/0002-9343(92)90620-Q
Larrison, 2004, Nicotine improves antisaccade task performance without affecting prosaccades, Hum. Psychopharmacol., 19, 409, 10.1002/hup.604
Larrison-Faucher, 2004, Nicotine reduces antisaccade errors in task impaired schizophrenic subjects, Prog. Neuropsychopharmacol. Biol. Psychiatry, 28, 505, 10.1016/j.pnpbp.2004.01.002
Lawrence, 2002, Cognitive mechanisms of nicotine on visual attention, Neuron, 36, 539, 10.1016/S0896-6273(02)01004-8
Leigh, 2006
Levin, 2006, Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization, Psychopharmacology (Berl), 184, 523, 10.1007/s00213-005-0164-7
Martin, 2004, Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia, Psychopharmacology (Berl), 174, 54, 10.1007/s00213-003-1750-1
Mason, 2007, Wandering minds: the default network and stimulus-independent thought, Science, 315, 393, 10.1126/science.1131295
Mazoyer, 2001, Cortical networks for working memory and executive functions sustain the conscious resting state in man, Brain Res. Bull., 54, 287, 10.1016/S0361-9230(00)00437-8
McDowell, 2002, Neural correlates of refixation saccades and antisaccades in normal and schizophrenia subjects, Biol. Psychiatry, 51, 216, 10.1016/S0006-3223(01)01204-5
McNamee, 2008, Brain activation, response inhibition, and increased risk for substance use disorder, Alcohol Clin. Exp. Res., 32, 405, 10.1111/j.1530-0277.2007.00604.x
Moon, 2007, Where left becomes right: a magnetoencephalographic study of sensorimotor transformation for antisaccades, Neuroimage, 36, 1313, 10.1016/j.neuroimage.2007.04.040
Mort, 2003, Differential cortical activation during voluntary and reflexive saccades in man, Neuroimage, 18, 231, 10.1016/S1053-8119(02)00028-9
Newhouse, 1997, Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics, Drugs Aging, 11, 206, 10.2165/00002512-199711030-00005
Newhouse, 2004, Nicotine and nicotinic receptor involvement in neuropsychiatric disorders, Curr. Top. Med. Chem., 4, 267, 10.2174/1568026043451401
O'Driscoll, 1995, Functional neuroanatomy of antisaccade eye movements investigated with positron emission tomography, Proc. Natl. Acad. Sci. U. S. A., 92, 925, 10.1073/pnas.92.3.925
Oldfield, 1971, The assessment and analysis of handedness: the Edinburgh inventory, Neuropsychologia, 9, 97, 10.1016/0028-3932(71)90067-4
Perkins, 1999, Baseline-dependency of nicotine effects: a review, Behav. Pharmacol., 10, 597, 10.1097/00008877-199911000-00006
Postma, 2006, A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia, Psychopharmacology (Berl), 184, 589, 10.1007/s00213-006-0307-5
Powell, 2002, Smoking, reward responsiveness, and response inhibition: tests of an incentive motivational model, Biol. Psychiatry, 51, 151, 10.1016/S0006-3223(01)01208-2
Raemaekers, 2006, Brain activation during antisaccades in unaffected relatives of schizophrenic patients, Biol. Psychiatry, 59, 530, 10.1016/j.biopsych.2005.07.030
Raemaekers, 2007, Test-retest reliability of fMRI activation during prosaccades and antisaccades, Neuroimage, 36, 532, 10.1016/j.neuroimage.2007.03.061
Reuter, 2004, Using saccade tasks as a tool to analyze executive dysfunctions in schizophrenia, Acta Psychol. (Amst), 115, 255, 10.1016/j.actpsy.2003.12.009
Russell, 1990, Non-smokers show acute tolerance to subcutaneous nicotine, Psychopharmacology (Berl), 102, 56, 10.1007/BF02245744
Rycroft, 2006, The antisaccade task as an index of sustained goal activation in working memory: modulation by nicotine, Psychopharmacology (Berl), 188, 521, 10.1007/s00213-006-0455-7
Rycroft, 2007, Non-cholinergic modulation of antisaccade performance: a modafinil–nicotine comparison, Psychopharmacology (Berl), 195, 245, 10.1007/s00213-007-0885-x
Shadmehr, 1997, Neural correlates of motor memory consolidation, Science, 277, 821, 10.1126/science.277.5327.821
Shrout, 1979, Intraclass correlations: uses in assessing rater reliability, Psychol. Bull., 86, 420, 10.1037/0033-2909.86.2.420
Smith, 2003, Applications of neuroreceptor imaging to psychiatry research, Psychopharmacol. Bull., 37, 26
Stein, 1998, Nicotine-induced limbic cortical activation in the human brain: a functional MRI study, Am. J. Psychiatry, 155, 1009, 10.1176/ajp.155.8.1009
Sweeney, 1996, Positron emission tomography study of voluntary saccadic eye movements and spatial working memory, J. Neurophysiol., 75, 454, 10.1152/jn.1996.75.1.454
Talairach, 1988
Thaker, 1991, Tobacco smoking increases square-wave jerks during pursuit eye movements, Biol. Psychiatry, 29, 82, 10.1016/0006-3223(91)90212-5
Thiel, 2005, Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex, Neuropsychopharmacology, 30, 810, 10.1038/sj.npp.1300633
Tu, 2006, Neural correlates of antisaccade deficits in schizophrenia, an fMRI study, J. Psychiatr. Res., 40, 606, 10.1016/j.jpsychires.2006.05.012
Wise, 2006, The role of fMRI in drug discovery, J. Magn. Reson. Imaging, 23, 862, 10.1002/jmri.20584